Black Diamond Therapeutic (BDTX) Stock Price, Quote, News & History

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer gen...

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Benzinga

Benzinga

Black Diamond Therapeutics Inc (BDTX) Stock Price, Quote, News & History

Key Statistics

Recent Black Diamond Therapeutics Inc News

Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data

4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals

Black Diamond Therapeutics Inks Licensing Pact With French Pharma Firm Servier For Its Early-Stage Cancer Drug Worth Over $700 Million

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Compare

FAQ

How do I buy Black Diamond Therapeutic (BDTX) stock?

Who are Black Diamond Therapeutic (BDTX) competitors?

What is the forecast, or price target, for Black Diamond Therapeutic (BDTX) stock?

What is the current price for Black Diamond Therapeutic (BDTX)?

Does Black Diamond Therapeutic (BDTX) pay a dividend?

When is Black Diamond Therapeutic (NASDAQ:BDTX) reporting earnings?

Is Black Diamond Therapeutic (BDTX) going to split?

What sector and industry does Black Diamond Therapeutic (BDTX) operate in?

People Also Watch

Key Statistics

Recent Black Diamond Therapeutics Inc News

Black Diamond's Lung Cancer Drug Shows 60% Response Rate In Phase 2 Data

4 Biotechnology Stocks Lead Momentum Gains Amid Strong Technicals

Black Diamond Therapeutics Inks Licensing Pact With French Pharma Firm Servier For Its Early-Stage Cancer Drug Worth Over $700 Million

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About

Edge Rankings

Stock Score Locked: Want to See it?

Bulls vs Bears

Compare

FAQ

How do I buy Black Diamond Therapeutic (BDTX) stock?

Who are Black Diamond Therapeutic (BDTX) competitors?

What is the forecast, or price target, for Black Diamond Therapeutic (BDTX) stock?

What is the current price for Black Diamond Therapeutic (BDTX)?

Does Black Diamond Therapeutic (BDTX) pay a dividend?

When is Black Diamond Therapeutic (NASDAQ:BDTX) reporting earnings?

Is Black Diamond Therapeutic (BDTX) going to split?

What sector and industry does Black Diamond Therapeutic (BDTX) operate in?

People Also Watch

Bulls vs Bears